Mirae Asset Global Etfs Holdings Ltd. Sutro Biopharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 30,913 shares of STRO stock, worth $122,106. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,913Holding current value
$122,106% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
124Shares Held
63MCall Options Held
200Put Options Held
27.6K-
Suvretta Capital Management, LLC New York, NY7.71MShares$30.4 Million0.94% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$27.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.45MShares$17.6 Million0.04% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.36MShares$17.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$14 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $206M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...